By Conjoint Associate Professor Mark Theo Bloch

Conference Abstracts

Martinello M; Bartlett S; Dore G; Bopage R; Finlayson R; Baker D; Bloch M; Doyle J; Shaw D; Hajkowicz K; Read P; Filep E; Lin L; Yee J; Applegate T; Hellard M; Matthews G, 2018, 'Universal access to DAA therapy paves the way for HCV control and elimination among people living with HIV in Australia', in Universal access to DAA therapy paves the way for HCV control and elimination among people living with HIV in Australia, Paris, France, presented at THE INTERNATIONAL LIVER CONGRESS 2018, Paris, France, 11 April 2018 - 15 April 2018

Martinello M; Dore GJ; Bopage RI; Finlayson R; Baker D; Bloch M; Wilcox A; Filep E; Hellard M; Matthews GV, 2017, 'FRI-194 DAA treatment scale-up in HIV/HCV co-infection: characterisinga population at risk for reinfection', in Journal of Hepatology, Elsevier, Vol. 66, pp. s495 - s496, http://dx.doi.org/10.1016/s0168-8278(17)31388-0

Back to profile page